Pax Labs Partners with: Aurora Cannabis, Aphria, Organiram, and Supreme Cannabis Co.



Pax Labs Partners with: Aurora Cannabis, Aphria, Organiram, and Supreme Cannabis Co. – RICH TV LIVE – JUNE 9, 2019 – Vape heavyweight Pax Labs Inc. is partnering with four Canadian cannabis producers to supply the domestic market with marijuana oil, ahead of the launch of new legal product formats in October.

Using cannabis through a vaporizer is widely expected to emerge as one of the most popular formats in the legal Canadian pot market given its popularity in American states that permit recreational cannabis use. It’s also a higher margin product relative to dried flower and believed to be key to introducing legal cannabis to users who aren’t fans of traditional methods of smoking the drug.

According to recent Scotiabank research report, vape products and cannabis concentrates represent roughly one-third of the total market in states such as California, Colorado, Nevada and Washington. For example, demand for vape products in Colorado accounted for 23 per cent of the legal market in 2017 from 12 per cent in 2014, while the use of cannabis flower declined to 54 per cent from 66 per cent during the same period.

“As new products such as vape pens are added to store shelves, we expect some customer spend to shift from the current flower and oil offerings,” Scotia analysts Ben Isaacson and Oliver Rowe wrote in the report released last month. “Additionally, these new formats could attract more users from the illicit channel, where the products are currently offered, increasing the size of the addressable legal market.”

Aphria Inc. (), Aurora Cannabis Inc. (), Organigram Holdings Inc. (OGI.V), and Supreme Cannabis Co. (FIRE.TO) will supply Pax with cannabis extracts, distillates, and resin for its Pax Era pen-and-pod vape system, a device similar to the Juul product which is a dominant player in the U.S. nicotine vape market.

Pax Labs quickly emerged as one of the biggest companies in the tobacco and cannabis sectors given the popularity of its devices which are used for vaporizing marijuana flower, oil, and waxy extracts, but it doesn’t grow or sell the plant.

Pax Labs founded Juul, which has about three-quarters of the U.S. vape market, and carved the company out as a standalone entity in 2017. Last December, tobacco giant Altria Group Inc. invested US$12.8 billion in Juul for a 35 per cent stake in the e-cigarette maker, valuing the company at US$38 billion.

As well, vaping has drawn the attention of practically every Canadian cannabis producer. While Health Canada’s final regulations on cannabis extracts and concentrates are yet to be released, most major pot companies are said to have a vape strategy in place despite not releasing much info on those products.

Ray Gracewood, senior vice-president for marketing at Organigram, said the company is earmarking about one-quarter of its cannabis for the concentrate market in anticipation for the demand it hopes to see for vape products. The company also plans to produce cartridges and disposable devices for the Canadian market, he added.

“We think the vaporzier market will be the second-biggest market next to dried flower in the short term and the biggest driver to get new consumers in the space,” he said in a phone interview with BNN Bloomberg.

Cowen & Co. analyst Vivien Azer said in a report on Wednesday that Cronos Group Inc. is expected to be a major player in the vape segment as it leverages its $2.4-billion strategic investment from Altria.

Azer said Cronos is using Altria’s old R&D facility in Israel to advance its next-generation vapor devices, which uses technology that Altria developed over the last several years for the tobacco market.

Disclaimer

RICH TV LIVE company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RICH TV LIVE reports company profiles or other investor relations materials and presentations are subject to change. RICH TV LIVE and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time. https://www.richtvlive.com/feature-.html
Investing is inherently risky. RICH TV LIVE is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission (“SEC”) at www.sec.gov/Canadian CSA https://www.securities-administrators.ca/.

source

%d bloggers like this: